Drugs / DTaP-IPV mkc vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00655148 Comparator | Sep 2003 → Oct 2006 | — | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP-IPV mkc vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00655148 ↗ |
| Known as | DTaP-IPVmkc | “B)The reference vaccine: DTaP-IPV containing IPV produced in monkey kidney cells (DTaP-IPVmkc)” NCT00655148 ↗ |
| Route | Intramuscular | “DTaP-IPV mkc 0.5 ml solution for intramuscular injection” NCT00655148 ↗ |